Amdocs (DOX) Projected to Post Earnings on Tuesday

Amdocs (NASDAQ:DOX) is anticipated to post its Q4 2025 results after the market closes on Tuesday, November 11th. Analysts expect Amdocs to post earnings of $1.82 per share and revenue of $1.1460 billion for the quarter. Investors may visit the the company’s upcoming Q4 2025 earningresults page for the latest details on the call scheduled for Wednesday, November 12, 2025 at 7:00 AM ET.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings results on Wednesday, August 6th. The technology company reported $1.72 earnings per share for the quarter, beating analysts’ consensus estimates of $1.71 by $0.01. Amdocs had a net margin of 11.94% and a return on equity of 19.66%. The firm had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.13 billion. During the same period last year, the company posted $1.62 EPS. Amdocs’s quarterly revenue was down 8.4% compared to the same quarter last year. On average, analysts expect Amdocs to post $6 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Amdocs Price Performance

NASDAQ:DOX traded up $0.31 during trading hours on Tuesday, hitting $84.44. 55,056 shares of the stock were exchanged, compared to its average volume of 749,342. The firm’s fifty day moving average price is $83.66 and its 200 day moving average price is $87.48. Amdocs has a 52-week low of $78.61 and a 52-week high of $95.41. The company has a market cap of $9.53 billion, a P/E ratio of 17.07, a P/E/G ratio of 1.40 and a beta of 0.51. The company has a current ratio of 1.22, a quick ratio of 1.22 and a debt-to-equity ratio of 0.23.

Amdocs Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Tuesday, September 30th were given a dividend of $0.527 per share. This represents a $2.11 annualized dividend and a dividend yield of 2.5%. The ex-dividend date was Tuesday, September 30th. Amdocs’s payout ratio is presently 42.60%.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Amdocs in a research note on Thursday, October 30th. Wolfe Research started coverage on shares of Amdocs in a research note on Tuesday, July 8th. They set an “outperform” rating for the company. Finally, Wall Street Zen upgraded Amdocs from a “hold” rating to a “buy” rating in a report on Saturday, October 11th. Three investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, Amdocs has an average rating of “Moderate Buy” and a consensus target price of $108.00.

Institutional Trading of Amdocs

A number of hedge funds and other institutional investors have recently made changes to their positions in DOX. Amundi grew its position in Amdocs by 73.0% in the first quarter. Amundi now owns 13,778 shares of the technology company’s stock worth $1,217,000 after acquiring an additional 5,816 shares during the period. Millennium Management LLC lifted its stake in shares of Amdocs by 458.3% in the 1st quarter. Millennium Management LLC now owns 67,047 shares of the technology company’s stock valued at $6,135,000 after purchasing an additional 55,038 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in shares of Amdocs by 12.6% during the 1st quarter. Goldman Sachs Group Inc. now owns 331,146 shares of the technology company’s stock worth $30,300,000 after purchasing an additional 37,087 shares during the period. Empowered Funds LLC increased its position in shares of Amdocs by 12.0% during the 1st quarter. Empowered Funds LLC now owns 15,979 shares of the technology company’s stock worth $1,462,000 after purchasing an additional 1,709 shares during the last quarter. Finally, Jane Street Group LLC increased its position in shares of Amdocs by 195.4% during the 1st quarter. Jane Street Group LLC now owns 115,929 shares of the technology company’s stock worth $10,608,000 after purchasing an additional 76,683 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Company Profile

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.